Radcliffe, Nathan M.
Shah, Manjool
Samuelson, Thomas W.
Article History
Received: 19 July 2023
Accepted: 29 September 2023
First Online: 19 October 2023
Declarations
:
: Dr. Nathan Radcliffe: consultant/fees from Allergan, Alcon, Glaukos, Sight Science, New World Medical, Lumenis, Belkin, Bausch and Lomb, Thea, and Iridex. Dr. Manjool Shah: to be submitted separately. Dr. Thomas W. Samuelson: consultant for Aerie Pharmaceuticals, Alcon Surgical, Allergan, Bausch & Lomb/Valeant, BELKIN Vision, ELT Sight, Equinox, Glaukos, Imprimis, Irisvision, Ivantis, Johnson & Johnson Vision, Ocuphire, MicroOptx, New World Medical, PolyActiva, Ripple Therapeutics, Santen, Sight Science, TearClear, Vialase, and Zeiss Meditec; and stock options from Belkin Vision, Equinox, Ivantis, Ocuphire, Sight Science, Tear Clear, and Vialase.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.